Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Aug 27, 2025; 17(8): 104568
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.104568
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.104568
Table 6 Quality of life scores, median (range)
Quality of life domain1 | Baseline | Post-treatment | P value |
Global health status/quality of life | 60 (40-80) | 75 (55-90) | < 0.001 |
Physical functioning | 55 (30-70) | 70 (50-85) | < 0.001 |
Role functioning | 50 (25-65) | 68 (45-80) | < 0.001 |
Social functioning | 58 (35-75) | 72 (50-88) | < 0.001 |
Fatigue | 65 (40-80) | 40 (20-60) | < 0.001 |
Pain | 60 (30-70) | 35 (15-50) | < 0.001 |
Nausea/vomiting | 50 (20-60) | 25 (10-40) | < 0.001 |
- Citation: Liu JY, Liang ZH, Liu JL, Li L, Cui B, Li TG. Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis. World J Gastrointest Surg 2025; 17(8): 104568
- URL: https://www.wjgnet.com/1948-9366/full/v17/i8/104568.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i8.104568